|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-2-14
|
|
pubmed:abstractText |
Patients with congenital coagulation disorders and chronic hepatitis C virus (HCV) infection have multiple risk factors (ie, infection predominantly with genotype-1 HCV, long duration of the disease, HIV coinfection and male sex) for poor response to antiviral therapy. The present study compared induction therapy with interferon-alpha (IFN-alpha)-2b with standard IFN-alpha2b therapy. Pegylated IFN was not available at the time that the study was initiated.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-10691851,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-11855562,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-11952848,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-12297845,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-12653888,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-14633177,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-14717986,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-14999598,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-15104664,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-15558712,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-15780416,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-16082736,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-8320743,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-9121257,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-9214474,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-9371165,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-9672169,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-9807989,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-9819446,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17299612-9819447
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0835-7900
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
91-5
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17299612-Adult,
pubmed-meshheading:17299612-Antiviral Agents,
pubmed-meshheading:17299612-Blood Coagulation Disorders,
pubmed-meshheading:17299612-Canada,
pubmed-meshheading:17299612-Comorbidity,
pubmed-meshheading:17299612-Drug Therapy, Combination,
pubmed-meshheading:17299612-Female,
pubmed-meshheading:17299612-Hepacivirus,
pubmed-meshheading:17299612-Hepatitis C, Chronic,
pubmed-meshheading:17299612-Humans,
pubmed-meshheading:17299612-Interferon-alpha,
pubmed-meshheading:17299612-Male,
pubmed-meshheading:17299612-Middle Aged,
pubmed-meshheading:17299612-RNA, Viral,
pubmed-meshheading:17299612-Recombinant Proteins,
pubmed-meshheading:17299612-Ribavirin
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trial.
|
|
pubmed:affiliation |
University of Toronto University Health Network, Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
